Back to speakers

Fabien ZOULIM

Professor of Medicine, Lyon University, Institut Universitaire de France // Medical Director, Hepatology Department at the Hospices Civils de Lyon, France // Scientific Director, Viral Hepatitis Research Laboratory, INSERM U1052, Cancer Research Center of Lyon, France

France

City: Lyon

Institution: Lyon University and INSERM

Contact: fabien.zoulim@inserm.fr


Biography of Fabien ZOULIM

Fabien Zoulim obtained his M.D. in Gastroenterology and Hepatology in Lyon Medical School in 1991. He has also obtained a PhD in Molecular and Cellular Biology and was trained as a post-doctoral researcher at Fox Chase Cancer Center in Philadelphia. He is Professor of Medicine at Lyon I University since 1997. He is currently Medical Director of the Hepatology Department at the Hospices Civils de Lyon, and Scientific Director of the Department of Immunology and Virology of INSERM Unit 1052 where he is leading the team on ‘Antiviral therapy of viral hepatitis’. Dr Zoulim has served as an Associate Editor for Journal of Hepatology and is currently Associate Editor for Gut. He also served as an expert in the microbiology study section of the INSERM and is currently head of the clinical viral hepatitis study section at ANRS. He served as a Governing Board member of the European Association for the Study of the Liver (EASL). Dr Zoulim received the William Prusoff award of the International Society for Antiviral Research. Furthermore, he has been the scientific coordinator of a European community-funded Network of Excellence on the management of antiviral drug resistance, and is currently head of the ANRS “HBV cure” program in France. Fabien Zoulim is a recognised expert in the field of viral hepatitis and antiviral therapy. He has published more than 350 articles (H index 63, Web of Science).

PHC's participations

10th PHC – 2017

Tuesday, January 31st 2017

New targets for HBV therapies

9th PHC – 2016

Tuesday, January 12th 2016

What's new in hepatitis B? (chairman)

Clinical relevance of HBV cccDNA -

Lunch Workshops - Room 252B (chairman)

8th PHC – 2015

Tuesday, January 13th 2015

The control of HBV related liver disease (chairman)

7th PHC – 2014

Tuesday, January 14th 2014

The control of HBV related liver disease (chairman)

6th PHC – 2013

Tuesday, January 15th 2013

Optimal management of patients with resistance -

5th PHC – 2012

Tuesday, January 31st 2012

Response unguided or guided ? (chairman) -

Interactive Luncheons - Room 4 -

4th PHC – 2011

Tuesday, January 18th 2011

Is resistance disappearing? -

3rd PHC – 2009

Tuesday, January 20th 2009

How to prevent, diagnose and overcome resistance under nucleos(t)ide analogs ? -

2nd PHC – 2007

Tuesday, January 23rd 2007

How to use virological tools for the optimal management of chronic hepatitis B -

1st PHC – 2004

Saturday, September 11th 2004

Clinical Virology of Hepatitis B (chairman) -

10th PHC – 2017

Tuesday, January 31st 2017

New targets for HBV therapies -